Low GI Diet Effects on Non-Alcoholic Fatty Liver Disease

NCT ID: NCT04415632

Last Updated: 2021-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

16 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-12-10

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A 2 x 2 cross-over dietary intervention trial designed to investigate the effects of low glycemic index (LGI) versus high glycemic index (HGI) diet on hepatic fat accumulation and gut microbiota composition in participants with NAFLD.

Participants will be allocated randomly to a 2-week either high GI (HGI) or low GI (LGI) diet followed by a 4-week wash-out period and then the LGI or HGI diet, opposite to the first 2-weeks (N= 16).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fatty Liver Nutritional and Metabolic Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

OTHER

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

LGI Diet

low glycemic index diet

Group Type EXPERIMENTAL

low glycemic index diet

Intervention Type OTHER

• Three-day cycle menu of LGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.

HGI Diet

High glycemic index diet

Group Type OTHER

High glycemic index diet

Intervention Type OTHER

Three-day cycle menu of HGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

low glycemic index diet

• Three-day cycle menu of LGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.

Intervention Type OTHER

High glycemic index diet

Three-day cycle menu of HGI diet will be designed and supplied to each participant in an amount designed to meet their estimated energy requirements. The percentage energy from protein, fat and carbohydrate will be the same in the two diets. Each diet period of the trial will last for two weeks.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

LGI HGI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* • Adult males and females aged from 18 to 65 years (balanced number).

* Detected NAFLD by CAP-FibroScan™ \>288dB/m or by MRI-PDFF) \> 5% fat of liver weight.
* Body mass index ≥ 25 kg/m2
* Have current moderate to high GI diet intake of ≥ 60 (Assessed from a completed 7-day food diary).
* Abdominal obesity (Waist circumference \> 102 cm for males and \> 88 cm for females)
* Able to give informed consent.
* Able to undergo MRI/S and CAP-FibroScan™.

Exclusion Criteria

* • Current smokers and excessive alcohol drinkers (\> 14 units/week).

* Perimenopausal (irregular periods) women.
* Participants with other liver abnormalities.
* Participants with history of gastrointestinal surgeries, depression, eating disorders or difficulties.
* Participants using pharmacologic agents for obesity or NAFLD.
* Participants with type 1 diabetes.
* Participants with type 2 diabetes on second line medications (eg GLP-1 analogues, sulfonylureas).
* Participation in any other trial in the last 3 months.
* Participants on any special diets (e.g. vegetarians).
* Intolerance to foods included in the diet plan.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Nottingham

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

NIHR Nottingham Clinical Research Facility Nottingham Digestive Diseases Centre

Nottingham, Nottinghamshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Amina Al-Awadi

Role: primary

+44 (0)115 823 1073

References

Explore related publications, articles, or registry entries linked to this study.

Al-Awadi A, Grove J, Taylor M, Valdes A, Vijay A, Bawden S, Gowland P, Aithal G. Effects of an isoenergetic low Glycaemic Index (GI) diet on liver fat accumulation and gut microbiota composition in patients with non-alcoholic fatty liver disease (NAFLD): a study protocol of an efficacy mechanism evaluation. BMJ Open. 2021 Oct 7;11(10):e045802. doi: 10.1136/bmjopen-2020-045802.

Reference Type DERIVED
PMID: 34620653 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

262245

Identifier Type: OTHER

Identifier Source: secondary_id

19/EM/0291

Identifier Type: OTHER

Identifier Source: secondary_id

19042

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Westlake Precision Nutrition Study
NCT05054153 COMPLETED NA